Analyst firms · Jefferies · ALXO

Jefferies ALXO price target and rating history

ALX Oncology Holdings Inc. (ALXO) · Health Care

Jefferies rates ALX Oncology Holdings Inc. (ALXO) Buy with a $4 price target, as of its latest action on Nov 13, 2025. It has published 5 rating actions on ALXO since December 2021, including 2 upgrades and 2 downgrades. Across 3 firms with a ALXO price target in the last 12 months, the median target is $5. Jefferies's $4 is 20% below that.

Current rating
Buy
Price target
$4
Median target, all firms
$5
Actions on ALXO
5

Jefferies price target on ALXO

$25$14$220222023202420252026
Jefferies price target on ALXO, each point a stated target, December 2021 to November 2025.

Every Jefferies rating on ALXO

How other firms rate ALXO

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoOverweight$5Mar 19, 2026
UBSBuy$6Mar 6, 2026
JefferiesBuy$4Nov 13, 2025

Questions about Jefferies and ALXO

What is Jefferies's price target for ALXO?
Jefferies's latest stated price target for ALX Oncology Holdings Inc. (ALXO) is $4, from its action on Nov 13, 2025.
What is Jefferies's rating on ALXO?
Jefferies rates ALXO Buy, a bullish rating, as of Nov 13, 2025.
When did Jefferies last change its view on ALXO?
On Nov 13, 2025, Jefferies starts coverage at Buy, price target $4.
How does Jefferies's ALXO target compare with other analysts?
Across 3 firms with a ALXO price target in the last 12 months, the median target is $5. Jefferies's $4 is 20% below that.

More ALXO rating histories

All Jefferies ratingsALXO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.